AABB's National Blood Foundation (NBF), established in 1983, serves the fields of transfusion medicine and cellular therapies through grant making, educational offerings, and industry leadership engagement and recognition.
NBF encourages innovation through early-career scientific research grants that supplement AABB's mission to further develop transfusion medicine, cellular therapies and regenerative medicine science. For almost forty years, the NBF's early-career grant program has funded more than 200 investigators – many of whom are now subject matter experts and leaders in the field.
Discoveries that may lead to improved therapeutic strategies for promoting platelet and red blood cell production in vitro and/or in vivo.
[Diane Krause, MD, PhD]
Confirming the reversibility of the platelet shape change during storage.
[Paul D. Mintz, MD]
Identifying the molecular mechanism for the Knops blood group antigens and developing methods for genotyping.
[Joann Moulds, Phd, MT (ASCP)SBB]
Development of mouse models of acute and delayed HTRs that mimic the complications seen in humans following a blood transfusion.
[Steven L. Spitalnik, MD]
Understanding the impact of the inflammatory status of transfusion recipients on RBC alloantibody formation.
[Jeanne E. Hendrickson, MD]
Discovering the Rh family of proteins were ammonia transporters, the first to be found in mammals, changing the paradigm of ammonia transport in human physiology.
[Connie Westhoff, SBB, PhD]
Development of a TRALI alternate pathophysiology and two-event model.
[Christopher Silliman, MD, PhD]
Identifying the SMM1 protein on the red blood cell membrane and confirming its absence or presence in red blood cells from Vel-negative and Vel-positive donors.
[Jill R. Storry, PhD]
NBF's recognition programs acknowledge prior NBF grant recipients annually. Our Hall of Fame celebrates lifetime achievement leaders who have made remarkable contributions to the field. NBF's scientific investigators are acknowledged through the Scholar Program.
By convening clinical and research leaders along with industry executives, NBF supports critical conversations among industry manufacturers, providers, and patient advocates. These conversations can spark innovation, enhance the exchange of ideas and confirm priorities.
Your contribution to the NBF helps us advance transfusion medicine and cellular therapies. by investing in the future leaders of the field and by providing opportunities for education and knowledge transfer. All donations are tax deductible. 501(c)(3) tax ID #36-2384118.
National Blood Foundation
Tax ID #36-2384118
4550 Montgomery Avenue
Suite 700 North Tower
Bethesda, MD, 20814
Phone +1.301.215.6552
Fax +1.301.686.7865
Email: nbf@aabb.org